Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) EPS (Basic) (2017 - 2024)

Historic EPS (Basic) for Lexaria Bioscience (LEXX) over the last 11 years, with Q2 2024 value amounting to $0.13.

  • Lexaria Bioscience's EPS (Basic) fell 6513.4% to $0.13 in Q2 2024 from the same period last year, while for May 2024 it was $0.13, marking a year-over-year decrease of 6513.4%. This contributed to the annual value of $1.01 for FY2023, which is 19006.91% up from last year.
  • Per Lexaria Bioscience's latest filing, its EPS (Basic) stood at $0.13 for Q2 2024, which was down 6513.4% from $0.06 recorded in Q1 2024.
  • Lexaria Bioscience's 5-year EPS (Basic) high stood at $0.37 for Q2 2023, and its period low was -$0.5 during Q2 2021.
  • Moreover, its 5-year median value for EPS (Basic) was $0.06 (2024), whereas its average is -$0.06.
  • Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 490000.0% in 2020, then surged by 24264.55% in 2023.
  • Lexaria Bioscience's EPS (Basic) (Quarter) stood at -$0.24 in 2020, then crashed by 45.02% to -$0.35 in 2021, then soared by 186.91% to $0.3 in 2022, then crashed by 56.17% to $0.13 in 2023, then decreased by 2.01% to $0.13 in 2024.
  • Its last three reported values are $0.13 in Q2 2024, $0.06 for Q1 2024, and $0.13 during Q4 2023.